HighMark Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$230K Sell
941
-11
-1% -$2.56K 0.09% 71
2025
Q4
$197K Buy
952
+22
+2% +$4.35K 0.08% 78
2025
Q3
$172K Sell
930
-237
-20% -$40.6K 0.08% 83
2025
Q2
$178K Buy
1,167
+210
+22% +$32.3K 0.09% 79
2025
Q1
$159K Sell
957
-92
-9% -$14.4K 0.09% 67
2024
Q4
$152K Sell
1,049
-189
-15% -$29.3K 0.09% 64
2024
Q3
$201K Buy
1,238
+9
+0.7% +$1.43K 0.11% 63
2024
Q2
$180K Buy
1,229
+10
+0.8% +$1.49K 0.11% 68
2024
Q1
$196K Buy
1,219
+9
+0.7% +$1.43K 0.12% 62
2023
Q4
$190K Buy
1,210
+9
+0.7% +$1.38K 0.14% 57
2023
Q3
$187K Buy
1,201
+9
+0.8% +$1.49K 0.16% 47
2023
Q2
$197K Buy
1,192
+9
+0.8% +$1.45K 0.15% 49
2023
Q1
$183K Buy
1,183
+9
+0.8% +$1.45K 0.14% 52
2022
Q4
$207K Sell
1,174
-35
-3% -$6.04K 0.16% 48
2022
Q3
$197K Sell
1,209
-28
-2% -$4.74K 0.17% 47
2022
Q2
$220K Buy
1,237
+2
+0.2% +$356 0.18% 43
2022
Q1
$219K Buy
1,235
+4
+0.3% +$681 0.15% 52
2021
Q4
$211K Buy
1,231
+7
+0.6% +$1.15K 0.13% 54
2021
Q3
$198K Sell
1,224
-3
-0.2% -$512 0.15% 50
2021
Q2
$202K Sell
1,227
-20
-2% -$3.31K 0.15% 48
2021
Q1
$205K Sell
1,247
-10
-0.8% -$1.62K 0.16% 47
2020
Q4
$198K Sell
1,257
-97
-7% -$14.3K 0.17% 46
2020
Q3
$202K Sell
1,354
-586
-30% -$86.7K 0.18% 43
2020
Q2
$273K Buy
1,940
+130
+7% +$18.9K 0.3% 33
2020
Q1
$237K Buy
1,810
+607
+50% +$86.1K 0.29% 30
2019
Q4
$175K Buy
+1,203
New +$163K 0.19% 40

Other funds holding JNJ

HighMark Wealth Management's JNJ Position: Q1 2026 in Review

HighMark Wealth Management reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q1 2026, selling an estimated $2.56K and leaving 941 shares worth $230K. The position accounts for 0.09% of the portfolio, ranked #71.

HighMark Wealth Management first reported a position in JNJ in Q4 2019 and has held it in 26 quarters since. The position peaked at $273K in Q2 2020. 4,612 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • HighMark Wealth Management held 941 shares of Johnson & Johnson worth $230K as of Q1 2026.
  • HighMark Wealth Management sold 11 Johnson & Johnson shares in Q1 2026, an estimated $2.56K.
  • Johnson & Johnson made up 0.09% of HighMark Wealth Management's portfolio in Q1 2026, its #71 holding.
  • HighMark Wealth Management first reported a position in Johnson & Johnson in Q4 2019 and has held it in 26 quarters since.
  • HighMark Wealth Management's Johnson & Johnson position peaked at $273K in Q2 2020.
  • 4,612 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on HighMark Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.